Bruce & Co

Robert Bruce

Period

Q4 2025

Portfolio Date

31 Dec 2025

Stocks Held

39

Market Value

$322.5M

Portfolio Analysis

AI

#### I. Institutional Overview The 13F filing for the fourth quarter of 2025 reveals a fascinating psychological and strategic portrait of **Robert Bruce - Bruce & Co**. With a reported portfolio value of approximately **$322.53 million** and a lean collection of just **39 holdings**, the institution exemplifies a "high-conviction, low-turnover" investment philosophy that is increasingly rare in an era dominated by high-frequency trading and algorithmic momentum strategies. Robert Bruce’s approach appears to be a modern iteration of classic value investing, characterized by deep fundamental research, extreme patience, and a willingness to hold positions for decades rather than quarters. Analyzing the scale of the institution, a portfolio value of $322.5 million places Bruce & Co in the category of a "boutique" investment manager. However, its influence and the clarity of its signals far outweigh its AUM (Assets Under Management). The fact that the firm manages only 39 stocks suggests a highly concentrated bet on specific business models and management teams. In the world of institutional finance, a portfolio with fewer than 40 stocks typically indicates that the manager is not seeking to "hug the index" or achieve diversification for the sake of safety. Instead, it suggests a "Best Ideas" approach where each position must clear a high bar of intrinsic value and long-term durability. The "Psychological Portrait" of Bruce & Co is one of **unwavering patience**. A cursory glance at the `holdingSince` data shows a staggering number of positions held for over a decade. Stocks like **ABBV (AbbVie)**, **ALL (Allstate)**, **DUK (Duke Energy)**, and **XEL (Xcel Energy)** have been cornerstones of this portfolio since 2013 or 2014. This longevity implies that Robert Bruce is not a "trader" but a "business owner." He views his 13F filings not as a series of tactical bets on price action, but as a collection of fractional ownerships in cash-flow-productive enterprises. This quarter’s data reinforces this narrative; the lack of any new positions or complete exits suggests a manager who is perfectly comfortable doing nothing when the market does not offer compelling new opportunities. Furthermore, the concentration in specific sectors—most notably **Healthcare (27.17%)** and **Utilities (23.76%)**—reveals a defensive and income-oriented mindset. Combined, these two sectors represent over 50% of the total portfolio. This is the hallmark of a manager who prioritizes capital preservation and steady compounding over speculative growth. By focusing on sectors with regulated returns (Utilities) and inelastic demand (Healthcare), Bruce & Co creates a "ballast" that can withstand significant market volatility. In summary, Robert Bruce - Bruce & Co enters 2026 as a bastion of **stability and conviction**. The institution’s scale is modest, but its commitment to its core holdings is absolute. The current state of the portfolio can be described as a "fortress of cash flow," where the primary activity is the quiet monitoring of long-term compounders rather than the frantic pursuit of the next market fad. This is a manager who understands that in investing, sometimes the most profitable action is inaction. #### II. Sector Allocation Analysis The sector allocation of Robert Bruce - Bruce & Co in Q4 2025 provides a clear window into the firm’s macroeconomic outlook and risk appetite. The portfolio is heavily skewed toward defensive, "real-world" industries, with a notable avoidance of the high-valuation volatility often found in the broader technology sector. | Sector | Weight (%) | Trend/Context | | :--- | :--- | :--- | | **Healthcare** | 27.17 | Core Defensive Pillar | | **Utilities** | 23.76 | Regulated Income Anchor | | **Industrials** | 19.26 | Cyclical Growth Kicker | | **Financials** | 8.91 | Interest Rate Sensitivity | | **Technology** | 6.34 | Selective Growth | | **Materials** | 5.09 | Inflation Hedge/Commodities | | **Consumer Staples** | 4.90 | Defensive Consumption | | **Communication Services** | 4.37 | Infrastructure & Media | | **Energy** | 0.21 | Minimal Exposure | **2.1 Concentration and Macro Judgment** The most striking feature of this allocation is the **extreme concentration** in the top three sectors. Healthcare, Utilities, and Industrials together account for **70.19%** of the total portfolio. This level of focus indicates a manager who has made a definitive judgment on where the most favorable risk-adjusted returns reside in the current economic cycle. The dominance of **Healthcare (27.17%)** suggests a belief in the long-term secular tailwinds of an aging global population and the continued pricing power of major pharmaceutical and medical device companies. By making Healthcare the largest sector, Bruce & Co is positioning itself to benefit from "recession-proof" earnings. Regardless of the macro-economic environment, demand for life-saving drugs and medical procedures remains constant. The heavy weight in **Utilities (23.76%)** serves as a strategic counterweight to market volatility. Utilities are often viewed as "bond proxies" due to their regulated earnings and consistent dividends. In a Q4 2025 environment—potentially characterized by stabilizing interest rates or a slowing economy—Utilities offer a safe haven. The firm’s massive exposure here suggests a preference for "certainty of return" over "magnitude of return." **2.2 Sector Rotation and Industry Insights** While the portfolio is defensive, the **19.26% allocation to Industrials** provides a necessary offensive component. This is not "traditional" manufacturing industrials, but rather specialized plays like **AER (AerCap Holdings)** and **UHAL (U-Haul)**. This allocation reveals a nuanced understanding of the "sharing economy" and global infrastructure. AerCap, as a leader in aviation leasing, benefits from the recovery and expansion of global travel, while U-Haul represents a dominant play in domestic logistics and self-storage. The relatively low exposure to **Technology (6.34%)** is a loud "silent signal." In a market often obsessed with AI and software-as-a-service (SaaS) multiples, Bruce & Co has chosen to remain largely on the sidelines. This suggests a valuation-sensitive approach. The firm likely views much of the tech sector as overextended or lacking the tangible cash-flow characteristics found in its preferred sectors. The tech exposure it *does* have, such as **AAPL (Apple)** and **VICR (Vicor)**, is highly selective and focused on hardware and power systems rather than speculative software. **2.3 Macroeconomic Inference** From this allocation, we can infer that Robert Bruce is preparing for a **"Lower for Longer" growth environment** or is hedging against a potential economic slowdown. The massive 51% combined weight in Healthcare and Utilities is a classic defensive posture. However, the 8.91% in Financials (led by Allstate) and the 5.09% in Materials (led by Newmont) suggest a hedge against persistent inflation or a "sticky" interest rate environment. The firm’s strategy appears to be: 1. **Anchor** the portfolio with regulated, high-yield Utilities. 2. **Grow** through dominant, wide-moat Healthcare and Industrial leaders. 3. **Protect** against tail risks with Financials and Materials. 4. **Avoid** the "noise" of high-multiple Technology. This is the allocation of a "Value Architect" who builds a portfolio to survive all seasons, prioritizing the return *of* capital as much as the return *on* capital. #### III. Top 10 Holdings Deep Dive The Top 10 holdings of Bruce & Co represent the "ballast stones" of the portfolio, accounting for a significant portion of the total AUM. These positions are not just investments; they are the embodiment of the firm's long-term conviction. **Table 3.1: Top 10 Holdings Detail** | Rank | Ticker | Company | Market Value | Weight (%) | Qtr Change | Weight Change | | :--- | :--- | :--- | :--- | :--- | :--- | :--- | | 1 | **ABBV** | AbbVie Inc. | $27.99M | ---